Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine)

European Journal of Haematology

Volumn 58, Issue 2, 1997, Pages 109-113

  Robak, T ^a   Blasinska Morawiec M ^a   Krykowski, E ^a   Hellmann, A ^b   Konopka, L ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Autoimmune haemolytic anaemia; Chlorodeoxyadenosine; Chronic lymphocytic leukaemia

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HEMOLYTIC ANEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0030995274     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00933.x     Document Type: Article

References (31)

1. CATOWSKY D, FOA R. B-cell chronic lymphocytic leukemia. In: The lymphoid leukaemias. London: Butterworth, 1990: 73-112.
2. GALE RP, FOON KA. Biology of chronic lymphocytic leukemia. Semin Hematol 1987: 4: 209-229.
3. FOON KA, RAI KR, GALE RP. Chronic lymphocytic leukemia: new insight into biology and therapy. Ann Intern Med 1990: 113: 525-539.
4. KIPPS TJ, CARSON WA. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 1993: 81: 2475-2487.
5. THOMPSON-MOYA L, MARTIN T, HEUFT HG, NEUBAUER A, HERRMAN R. Case report: allergic reaction with immune hemolytic anemia resulting from chlorambucil. Am J Haematol 1989: 32: 230-231.
6. BEUTLER E, PIRO LD, SAVEN A et al. 2-Chlorodeoxyadenosine (2-CdA): a potent chemotherapeutic and immunosuppressive nucleoside. Leuk Lymph 1991: 5: 1-8.
7. ROBAK T, BLASIŃSKA-MORAWIEC M, KRYKOWSKI E, et al. 2-Chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymph 1996: 22: 107-111.
8. TALLMAN MS, HAKIMIAN D. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 1995: 86: 2463-2474.
9. PIRO LD, CARRERA CJ, BEUTLER E, CARSON DA. 2-Chlorodeoxydenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988: 72: 1069-1073.
10. JULIUSSON G, LILIEMARK J. High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol 1993: 11: 679-689.
11. ROBAK T, BLASIŃSKA-MORAWIEC M, KRYKOWSKI E, et al. Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia. Leuk Lymph 1996: 22: 509-514.
12. DI RAIMONDO F, GIUSTOLISI R, CACCIDA E, KONTARJIAN H, ROBERTON LB, KEATING MJ. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymph 1993: 11: 63-68.
13. MYINT H, COPPLESTONE JA, ORCHARD J, et al. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995: 91: 341-344.
14. MACLEAN R, MEIKLEJOHN D, SOUTAR R. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1996: 92: 768-769.
15. ZAUCHA JM, HALABURDA K, CIEPŁUCH H, HELLMANN A. 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis. Acta Haematol Pol 1994: 25: 119-127.
16. FLEISCHMAN RA, CROY D. Acute onset of severe autoimmune hemolytic anemia after treatment with 2-chlorodeoxyadenosine for chronic lymphocytic leukemia. Am J Hematol 1995: 48: 293.
17. RAI KR, SAVITSKY A, CRONKITE EP, CHANNA AD, LEVY RN, PASTERNACK BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975: 46: 219-234.
18. KAZIMIERCZUK Z, COTTAM HB, RAVANLIAR GR, ROBINS RK. Synthesis of 2′-deoxytubercidin, 2′-deoxyadenosin and related 2′-deoxynucleosides via a novel direct stereospecific serum salt glycosylation procedure. J Am Chem Soc 1984: 106: 6379-6382.
19. CHESON BD, BENNETT JM, RAI KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia. Recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 1988: 29: 152-163.
20. DIGHIERO G, TRAVADE P, CHEVRET S, et al. B-cell chronic lymphocytic leukemia: present status and future directions. Blood 1991: 78: 1901-1914.
21. BEROSAGEL DE. The chronic leukemias: a review of disease manifestations and the aim of therapy. Can Med Assoc J 1967: 96: 1615-1620.
22. FOA R. Pathogenesis of the immunodeficiency of B-cell chronic lymphocytic leukemia. In: CHESON BD, ed. Chronic lymphocytic leukemia. Scientific advances and clinical developments. New York: Marcel Dekker, 1993: 147-166.
23. DE ROSSI G, GRANATI L, GIRELLI G, et al. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). Nouv Rev Fr Hematol 1988: 30: 403-406.
24. HANSEN MM. Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time. Scand J Haematol 1973: 18 (Suppl 1): 282.
25. MAYER R, STANE K, HAN A, BONA C. Malignant CD5 B cells biased immunoglobulin variable gene usage and autoantibody production. Int Rev Immunol 1991: 7: 189-203.
26. INGHIRAMI G, GOITL DR, SABICHI A, ZHU BY, KNOWLES DM. Autoantibody-associated cross-reactive idiotype-bearing human B lymphocytes: distribution and characterization, including IgVH gene and CD5 antigenic expression. Blood 1991: 78: 1503-1515.
27. STHOEGER ZU, WAKAI M, TSE DB, et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989: 169: 255-268.
28. JEFFERIES L. Transfusion therapy in autoimmune haemolytic anaemia. Hematol Oncol Clin N Am 1994: 8: 1087-1104.
29. SCHROEDER JR HW, DIGHIERO G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today, 1994: 15: 288-294.
30. PELLER S, KAUFMANN S. Decreased CD45RA T-cells in B-cell chronic lymphocytic leukemia patients: correlation with disease stage. Blood 1991: 78: 1569-1573.
31. FIGUERDA M, MCMILLAN R. 2-Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura. Blood 1993: 3484-3485.